Ephedrine and phenylephrine
Reading File
Asking for Preferences
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Searching PubMed
ephedrine phenylephrine spinal anesthesia hypotension
I now have comprehensive data from multiple authoritative sources. Here is a full comparative overview:
Ephedrine vs. Phenylephrine
1. Chemical Classification & Mechanism of Action
| Feature | Ephedrine | Phenylephrine |
|---|---|---|
| Class | Noncatecholamine phenylisopropylamine | Noncatecholamine synthetic sympathomimetic |
| Mechanism | Mixed-acting — indirect (displaces NE from presynaptic vesicles) + direct α and β agonism | Direct-acting — selective α₁ agonist only |
| Receptor profile | α₁, α₂, β₁, β₂ (all adrenoceptors) | Almost exclusively α₁ |
| Dependence on NE stores | Yes — requires intact NE stores; blocked by reserpine/cocaine | No — acts directly on postsynaptic receptor |
Mechanistic detail (Barash): Ephedrine is endocytosed into adrenergic nerve terminals where it displaces NE from synaptic vesicles. Released NE then activates postsynaptic receptors. Phenylephrine lacks a hydroxyl group on the phenyl ring (unlike epinephrine), which abolishes β-receptor activity.
2. Cardiovascular Effects
| Parameter | Ephedrine | Phenylephrine |
|---|---|---|
| Blood pressure | ↑ (via ↑CO + ↑SVR) | ↑ (via ↑SVR alone) |
| Heart rate | ↑ (β₁ stimulation) | ↓ (reflex bradycardia via baroreceptors) |
| Cardiac output | ↑ | ↓ or unchanged (normal LV) |
| SVR | Variable increase | Marked increase |
| Contractility | ↑ | No direct effect |
| Arrhythmogenicity | Yes (β₁ effect) | No — not arrhythmogenic |
Ephedrine resembles epinephrine in its initial cardiovascular profile — raising HR, CO, and SVR together. Phenylephrine raises BP solely by vasoconstriction; baroreceptor activation then slows the heart. — Barash, Clinical Anesthesia, 9e
In heart failure (HFrEF): Phenylephrine can precipitate a drop in CO because the failing ventricle is very sensitive to afterload increases. Ephedrine is generally preferred in this context.
3. Tachyphylaxis
- Ephedrine: Rapid tachyphylaxis occurs with repeated dosing because presynaptic NE stores are depleted and ephedrine itself is released as a "false neurotransmitter."
- Phenylephrine: Also subject to tachyphylaxis with infusions, requiring upward titration — but the mechanism is receptor desensitization, not NE depletion.
4. Pharmacokinetics
| Parameter | Ephedrine | Phenylephrine |
|---|---|---|
| Bioavailability | High (orally active) | Parenteral or topical for systemic use |
| Duration (IV bolus) | Longer (minutes–hours) | ~15 min |
| Half-life | 3–6 h | Short |
| Elimination | Urinary excretion largely unchanged | Hepatic |
| CNS penetration | Yes — CNS stimulant | Minimal |
5. Clinical Uses
Ephedrine
- Hypotension during anesthesia (especially when accompanied by bradycardia — the classic indication)
- Hypotension from spinal/neuraxial anesthesia
- Bronchodilation (largely replaced by selective β₂ agonists)
- Urinary continence (stimulates α receptors at bladder neck)
- Nasal congestion (decongestant)
Phenylephrine
- Hypotension with normal or elevated heart rate (opposite indication to ephedrine)
- Spinal anesthesia–induced hypotension — preferred agent for prophylactic infusion in cesarean delivery
- Nasal decongestant (oral/topical; has replaced pseudoephedrine in many OTC products)
- Mydriasis (ophthalmic drops)
- Paroxysmal supraventricular tachycardia (reflex vagal slowing)
6. Neuraxial Anesthesia & Obstetrics (Key Clinical Comparison)
This is the most clinically discussed head-to-head comparison:
"Ephedrine and phenylephrine are the most used vasopressors for prevention and treatment of hypotension associated with neuraxial anesthesia. In parturients during cesarean section, ephedrine raises blood pressure primarily by increasing stroke volume and cardiac output. Phenylephrine increases systemic vascular resistance and decreases cardiac output." — Barash, Clinical Anesthesia, 9e
Fetal/neonatal relevance: Phenylephrine is now generally preferred in obstetric spinal anesthesia because ephedrine crosses the placenta and can stimulate fetal metabolism, leading to lower fetal pH (fetal acidosis). Phenylephrine does not have this effect to the same degree.
Prophylactic infusion vs. bolus (phenylephrine): A prophylactic phenylephrine infusion results in fewer interventions and less nausea than rescue bolus dosing. — Barash, Clinical Anesthesia, 9e
7. Side Effects & Adverse Effects
| Ephedrine | Phenylephrine | |
|---|---|---|
| Hypertension | Yes (can be marked) | Yes (dose-dependent) |
| Tachycardia | Yes | No (causes bradycardia) |
| Arrhythmias | Risk present (β₁ stimulation) | Minimal arrhythmia risk |
| CNS stimulation | Yes — insomnia, anxiety | No |
| Urinary retention | Yes (α receptor at bladder neck; especially in BPH) | Minimal |
| Reflex bradycardia | No | Yes — clinically significant |
| Pulmonary hypertension | Less concern | Can ↑ pulmonary artery pressures |
| Hypertensive headache | Yes (with overdose) | Yes (with large doses) |
8. Contraindications / Cautions
| Ephedrine | Phenylephrine | |
|---|---|---|
| Cardiovascular disease | Caution — arrhythmias, unrecognized coronary disease | Caution — afterload-sensitive states (HFrEF) |
| MAO inhibitor use | Contraindicated — severe hypertensive crisis | Also caution |
| BPH | Caution — urinary retention | Less concern |
| Bradycardia | Good choice (raises HR) | Avoid — worsens bradycardia |
| Tachycardia | Avoid — raises HR further | Preferred choice |
9. Dosing (Clinical Anesthesia Context)
| Ephedrine | Phenylephrine | |
|---|---|---|
| IV bolus | 5–25 mg | 50–100 mcg (0.5–1 mcg/kg) |
| Infusion | 5–25 mg/h (titrated) | 25–100 mcg/min (titrated) |
| Concentration | Typically 5 mg/mL | Usually diluted to 100 mcg/mL from 1% solution |
10. Summary: When to Choose Each
| Situation | Preferred Agent |
|---|---|
| Hypotension + bradycardia | Ephedrine |
| Hypotension + tachycardia | Phenylephrine |
| Spinal anesthesia in cesarean delivery | Phenylephrine (better fetal outcomes) |
| Bronchospasm with hypotension | Ephedrine |
| Pure vasoplegia (vasodilatory shock) | Phenylephrine |
| Known cardiac dysfunction (HFrEF) | Caution with phenylephrine; prefer ephedrine or inotropes |
| Mydriasis needed | Phenylephrine (topical) |
| Nasal decongestion | Both available; phenylephrine OTC |
Sources: Morgan & Mikhail's Clinical Anesthesiology, 7e | Barash, Cullen & Stoelting's Clinical Anesthesia, 9e | Goodman & Gilman's Pharmacological Basis of Therapeutics | Katzung's Basic & Clinical Pharmacology, 16e | Lippincott Illustrated Reviews: Pharmacology
Can you make not of individual drug include moa, pharmacokinetics, indications, adv effect, dose interaction
Checking Date & Time
Asking for Preferences
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Running Command
Writing File
You've run out of free credits. Sign up for a free account to continue using Orris.
This is a shared conversation. Sign in to Orris to start your own chat.